HCA Healthcare Capital Expenditures (CapEx) Growth & History (HCA)
HCA Healthcare's capital expenditures (capex) was $4.94B for fiscal 2025.
View full HCA Healthcare company overviewHCA Healthcare annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.94B | $69.0M | +1.42% |
| 2024 | 2024-12-31 | $4.88B | $131.0M | +2.76% |
| 2023 | 2023-12-31 | $4.74B | $349.0M | +7.94% |
| 2022 | 2022-12-31 | $4.39B | $818.0M | +22.87% |
| 2021 | 2021-12-31 | $3.58B | $742.0M | +26.17% |
| 2020 | 2020-12-31 | $2.83B | −$1.32B | −31.82% |
| 2019 | 2019-12-31 | $4.16B | $585.0M | +16.37% |
| 2018 | 2018-12-31 | $3.57B | $558.0M | +18.51% |
| 2017 | 2017-12-31 | $3.02B | $255.0M | +9.24% |
| 2016 | 2016-12-31 | $2.76B | $385.0M | +16.21% |
| 2015 | 2015-12-31 | $2.38B | $199.0M | +9.15% |
| 2014 | 2014-12-31 | $2.18B | $233.0M | +11.99% |
| 2013 | 2013-12-31 | $1.94B | $81.0M | +4.35% |
| 2012 | 2012-12-31 | $1.86B | $183.0M | +10.90% |
| 2011 | 2011-12-31 | $1.68B | $354.0M | +26.72% |
| 2010 | 2010-12-31 | $1.32B | $8.0M | +0.61% |
| 2009 | 2009-12-31 | $1.32B | — | — |
HCA Healthcare quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.23B | $55.0M | +4.68% |
| Q1 2026 | 2026-03-31 | $1.12B | $128.0M | +12.92% |
| Q4 2025 | 2025-12-31 | $1.49B | $204.0M | +15.88% |
| Q3 2025 | 2025-09-30 | $1.29B | $97.0M | +8.14% |
| Q2 2025 | 2025-06-30 | $1.18B | −$105.0M | −8.20% |
| Q1 2025 | 2025-03-31 | $991.0M | −$127.0M | −11.36% |
| Q4 2024 | 2024-12-31 | $1.28B | $126.0M | +10.87% |
| Q3 2024 | 2024-09-30 | $1.19B | $44.0M | +3.84% |
| Q2 2024 | 2024-06-30 | $1.28B | $40.0M | +3.22% |
| Q1 2024 | 2024-03-31 | $1.12B | −$79.0M | −6.60% |
| Q4 2023 | 2023-12-31 | $1.16B | −$164.0M | −12.40% |
| Q3 2023 | 2023-09-30 | $1.15B | $16.0M | +1.41% |
| Q2 2023 | 2023-06-30 | $1.24B | $161.0M | +14.91% |
| Q1 2023 | 2023-03-31 | $1.20B | $336.0M | +39.02% |
| Q4 2022 | 2022-12-31 | $1.32B | $131.0M | +10.99% |
| Q3 2022 | 2022-09-30 | $1.13B | $242.0M | +27.22% |
| Q2 2022 | 2022-06-30 | $1.08B | $238.0M | +28.27% |
| Q1 2022 | 2022-03-31 | $861.0M | $207.0M | +31.65% |
| Q4 2021 | 2021-12-31 | $1.19B | $444.0M | +59.36% |
| Q3 2021 | 2021-09-30 | $889.0M | $400.0M | +81.80% |
| Q2 2021 | 2021-06-30 | $842.0M | $97.0M | +13.02% |
| Q1 2021 | 2021-03-31 | $654.0M | −$199.0M | −23.33% |
| Q4 2020 | 2020-12-31 | $748.0M | −$526.0M | −41.29% |
| Q3 2020 | 2020-09-30 | $489.0M | −$650.0M | −57.07% |
| Q2 2020 | 2020-06-30 | $745.0M | −$219.0M | −22.72% |
| Q1 2020 | 2020-03-31 | $853.0M | $72.0M | +9.22% |
| Q4 2019 | 2019-12-31 | $1.27B | $121.0M | +10.49% |
| Q3 2019 | 2019-09-30 | $1.14B | $293.0M | +34.63% |
| Q2 2019 | 2019-06-30 | $964.0M | $84.0M | +9.55% |
| Q1 2019 | 2019-03-31 | $781.0M | $87.0M | +12.54% |
| Q4 2018 | 2018-12-31 | $1.15B | $171.0M | +17.41% |
| Q3 2018 | 2018-09-30 | $846.0M | $117.0M | +16.05% |
| Q2 2018 | 2018-06-30 | $880.0M | $147.0M | +20.05% |
| Q1 2018 | 2018-03-31 | $694.0M | $123.0M | +21.54% |
| Q4 2017 | 2017-12-31 | $982.0M | $106.0M | +12.10% |
| Q3 2017 | 2017-09-30 | $729.0M | $17.0M | +2.39% |
| Q2 2017 | 2017-06-30 | $733.0M | $70.0M | +10.56% |
| Q1 2017 | 2017-03-31 | $571.0M | $62.0M | +12.18% |
| Q4 2016 | 2016-12-31 | $876.0M | $72.0M | +8.96% |
| Q3 2016 | 2016-09-30 | $712.0M | $145.0M | +25.57% |
| Q2 2016 | 2016-06-30 | $663.0M | $105.0M | +18.82% |
| Q1 2016 | 2016-03-31 | $509.0M | $63.0M | +14.13% |
| Q4 2015 | 2015-12-31 | $804.0M | $110.0M | +15.85% |
| Q3 2015 | 2015-09-30 | $567.0M | −$2.0M | −0.35% |
| Q2 2015 | 2015-06-30 | $558.0M | $45.0M | +8.77% |
| Q1 2015 | 2015-03-31 | $446.0M | $46.0M | +11.50% |
| Q4 2014 | 2014-12-31 | $694.0M | $98.0M | +16.44% |
| Q3 2014 | 2014-09-30 | $569.0M | $118.0M | +26.16% |
| Q2 2014 | 2014-06-30 | $513.0M | $21.0M | +4.27% |
| Q1 2014 | 2014-03-31 | $400.0M | −$4.0M | −0.99% |
| Q4 2013 | 2013-12-31 | $596.0M | $2.0M | +0.34% |
| Q3 2013 | 2013-09-30 | $451.0M | −$33.0M | −6.82% |
| Q2 2013 | 2013-06-30 | $492.0M | $43.0M | +9.58% |
| Q1 2013 | 2013-03-31 | $404.0M | $69.0M | +20.60% |
| Q4 2012 | 2012-12-31 | $594.0M | $85.0M | +16.70% |
| Q3 2012 | 2012-09-30 | $484.0M | $90.0M | +22.84% |
| Q2 2012 | 2012-06-30 | $449.0M | $2.0M | +0.45% |
| Q1 2012 | 2012-03-31 | $335.0M | $6.0M | +1.82% |
| Q4 2011 | 2011-12-31 | $509.0M | $44.0M | +9.46% |
| Q3 2011 | 2011-09-30 | $394.0M | $70.0M | +21.60% |
| Q2 2011 | 2011-06-30 | $447.0M | $125.0M | +38.82% |
| Q1 2011 | 2011-03-31 | $329.0M | $115.0M | +53.74% |
| Q4 2010 | 2010-12-31 | $465.0M | — | — |
| Q3 2010 | 2010-09-30 | $324.0M | — | — |
| Q2 2010 | 2010-06-30 | $322.0M | — | — |
| Q1 2010 | 2010-03-31 | $214.0M | — | — |
HCA Healthcare capital expenditures (capex) trends
Over the last five fiscal years, HCA Healthcare's capital expenditures (capex) increased from $2.83B to $4.94B, a change of $2.11B. The latest reported quarter, Q2 2026, shows $1.23B.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HCA Healthcare source filings ↗